SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019987
Filing Date
2023-06-02
Accepted
2023-06-02 16:35:35
Documents
12
Period of Report
2023-06-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37480
  Complete submission text file 0001493152-23-019987.txt   212458

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ensc-20230602.xsd EX-101.SCH 3224
3 XBRL LABEL FILE ensc-20230602_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ensc-20230602_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3771
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 23989475
SIC: 2834 Pharmaceutical Preparations